Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI

BACKGROUND: Osteogenesis imperfecta (OI) is a hereditary disease causing reduced bone mass, increased fracture rate, long bone deformities and vertebral compressions. Additional non skeletal findings are caused by impaired collagen function and include hyperlaxity of joints and blue sclera. Most OI...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoyer-Kuhn, Heike, Netzer, Christian, Koerber, Friederike, Schoenau, Eckhard, Semler, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180531/
https://www.ncbi.nlm.nih.gov/pubmed/25257953
http://dx.doi.org/10.1186/s13023-014-0145-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180531/
https://www.ncbi.nlm.nih.gov/pubmed/25257953
http://dx.doi.org/10.1186/s13023-014-0145-1

Ejemplares similares